Trials / Recruiting
RecruitingNCT07279714
Fisetin in Mild Alzheimer's Disease
Fisetin Intervention Study in Mild Alzheimer's Disease
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Sunnybrook Health Sciences Centre · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Conditions
- Alzheimer s Disease
- Alzheimer Dementia
- Alzheimer Dementia (AD)
- Alzheimer Disease
- Mild Cognitive Disorder
- Neurocognitive Disorders, Mild
- Neurocognitive Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fisetin | Fisetin 20mg/kg/day |
Timeline
- Start date
- 2026-01-27
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2025-12-12
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07279714. Inclusion in this directory is not an endorsement.